PHAS - PhaseBio Pharmaceuticals Inc
Previous close
0.0701
0 0%
Share volume: 0
Last Updated: Wed 02 Nov 2022 05:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
Summary score
46%
Profitability
50%
Dept financing
11%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.85%
Return on assets
-20.41%
Return on sales
0%
Return on invested capital
243.19%
Total debt ratio
75.62%
Debt ratio change over timeo
0.73%
Current Ratio
8.52%
Quick Ratio
0%
Cash Position Ratio
8.02%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-42.37%
Return on assets
-20.32%
Return on sales
0%
Return on invested capital
332.76%
Total debt ratio
34.57%
Debt ratio change over timeo
-0.9%
Current Ratio
9.13%
Quick Ratio
0%
Cash Position Ratio
8.34%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-106.63%
Return on assets
-34.03%
Return on sales
0%
Return on invested capital
262.2%
Total debt ratio
62.73%
Debt ratio change over time
-0.87%
Current Ratio
3.58%
Quick Ratio
0%
Cash Position Ratio
2.98%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-121.36%
Return on assets
-132.69%
Return on sales
0%
Return on invested capital
82.81%
Total debt ratio
73.48%
Debt ratio change over time
0.73%
Current Ratio
4.49%
Quick Ratio
0%
Cash Position Ratio
4.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHAS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -21.85% | 0% | 0% | 29.06% |
| Return on assets | -20.41% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 243.19% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 30% |
| Total debt ratio | 75.62% | 0% | 0% | 183.15% |
| Debt ratio change over time | 0.73% | 0% | 0% | 19.02% |
| Dept financing | 11% | 0% | 0% | 50% |
| Current Ratio | 9.13% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 8.34% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 49% |
| Short-term ratios | PHAS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -42.37% | 0% | 0% | -16.12% |
| Return on assets | -20.32% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 332.76% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 7% |
| Total debt ratio | 34.57% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.9% | 0% | 0% | 0.09% |
| Dept financing | 11% | 0% | 0% | 50% |
| Current Ratio | 9.13% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 8.34% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 58% |